Abstract
This Health Industry Insights report provides guidance on life science IT spending trends based on a detailed evaluation of survey results. This research further evaluates how spending sentiment and behavior differ by various industry subsegments based on company size (1,000 or more employees and fewer than 1,000 employees), organization type (pharmaceutical, biotech, government, academia/research hospital, and CRO/CMO), and functional area (basic research, preclinical drug development, clinical trials, manufacturing/distribution, and sales and marketing). Health Industry Insights' Leading Indicators in Life Science
IT Spending Survey is a quarterly research effort that probes end-user opinions throughout the life science value chain on planned IT spending, technology adoption attitudes, perspectives on leading vendors, and other IT-related topics. This data was gathered via a Web-based survey that yielded 154 participants, 63% of whom were manager level or above within their respective organizations.
Eric Newmark, a research manager at Health Industry Insights, stated, "IT spending growth has slowed a bit from last quarter, but still remains relatively strong with 26% of the industry expecting to increase overall IT spend in 2008. Decreased research and development productivity has caused the industry to circulate ancillary spending back into innovation, which has helped push research applications up in terms of investment priority. Companies are now heavily focused on any activity that will help drive dollars toward long-term pipeline development, so efforts such as IT outsourcing are beginning to heat up."
Table of Contents
- Table of Contents
- Health Industry Insights Opinion
- In This Report
- Methodology
- Weighting Methodology
- Organizational Demographics
- Table: Respondents by Type of Organization
- Table: Respondents by Company Revenue, 2007
- Respondent Demographics
- Table: Respondents by Functional Area
- Table: Respondents by Level of Responsibility
- Table: Respondents by Extent of Decision-Making Influence
- Methodology
- Situation Overview
- Executive Summary
- IT Budget Focus: Hardware, Software, and Services
- Figure: Expected Change in Organizational IT Budget over the Next 12 Months by Segment
- Figure: Reasons for Expected Functional Area Budget Increase, 2Q07-1Q08
- Survey Findings
- Compliance and IT Spending
- IT Spending by Type of Technology
- Figure: Compliance Drivers of IT Spending, 2Q07-1Q08
- Table: Expected IT Spending Change by Area (% of Respondents)
- Budget Priorities for IT Spending
- Favored Vendors for Overall IT Spending
- Figure: First and Second Budget Priorities by Core IT Spending Segment
- Figure: Vendors Planned for IT Spending over the Next Six Months by Segment
- Differential Adoption by Pharma and Biotech for Leading Personalized Medicine Processes
- Figure: Detailed Adoption Growth in Targeted Therapeutics Processes in Pharmaceutical and Biotechnology Companies - Maturity of Targeted Therapeutics in Pharma and Biotech Companies
- Figure: Detailed Adoption Growth of Electronic Medical Records in Pharmaceutical and Biotechnology Companies - Maturity of EMRs in Pharma and Biotech Companies
- Executive Summary
- Future Outlook
- Essential Guidance
- Learn More
- Related Research
- Synopsis
